Microfluidics Market

7500+ companies worldwide approach us every year for their revenue growth inititatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025

FREE BROCHURE FREE SAMPLE REPORT

Report Code: AST 7541 May, 2020, by marketsandmarkets.com

COVID-19

Get in-depth analysis of the COVID-19 impact on the Microfluidics Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Microfluidics Market

Request For Special Pricing

[286 Pages Report] The global microfluidics market size is expected to reach USD 44.0 billion by 2025 from an estimated value of USD 15.7 billion in 2020, growing at a CAGR of 22.9% during the forecast period. Several factors, such as the rising demand for point-of-care testing, technological advancements, increasing focus on data precision & accuracy, fast returns on investment and faster testing & improved portability through microfluidic chip miniaturization, are driving the market.

Besides, the emergence of microfluidics-based 3D cell culture systems, such as organ-on-a-chip and expanding applications of drug delivery technologies, offers significant growth opportunities for players operating in the market. However, there are certain challenges in incorporating microfluidics technology into existing workflows. This, coupled with the presence of complex and time-consuming regulatory standards, are the major factors restraining the growth of the microfluidics market.

Microfluidics Market, by Region, 2023 (USD Billion)

The microfluidic-based devices segment is projected to grow at the highest CAGR during the forecast period

Based on products, the market is segmented into microfluidic-based devices and microfluidic components. The microfluidic-based devices segment is expected to grow at the highest rate during the forecast period. The large share and high growth of this segment can primarily be attributed to the increasing adoption of microfluidic devices owing to the various advantages offered by the microfluidic technology, such as rapid testing and low sample and reagent consumption.

The in-vitro diagnostics segment is projected to grow at the highest CAGR during the forecast period

Based on application, the microfluidics market is segmented into in-vitro diagnostics, pharmaceutical, life science research & manufacturing, and therapeutics. The in-vitro diagnostics segment is expected to grow at the highest rate during the forecast period. The large share and high growth of this segment can be attributed to the high adoption of microfluidic techniques in laboratory analytical testing and point-of-care testing, growing demand for point-of-care testing, increasing need for miniaturized and portable diagnostic equipment, and the increasing incidence of chronic diseases.

In 2019, the hospitals and diagnostic centers' segment accounted for the largest share of the market

Based on end-users, the market has been segmented into hospitals & diagnostic centers, academic & research institutes, and pharmaceutical & biotechnology companies. The hospitals & diagnostic centers segment accounted for the largest share of the microfluidics market in 2019. This is primarily due to the increasing use of microfluidic techniques for the rapid diagnosis of various chronic diseases, technological advancements, and the inherent advantages of microfluidics technology. The need for closer monitoring and faster diagnosis are also factors driving the growth of this end-user segment.

Microfluidics Market, by Region, 2023 (USD Billion)

North America accounted for the largest share of the global microfluidics industry in 2019

The global microfluidics market study is analyzed into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the market. This can be attributed to the increasing demand for PoC testing, increasing incidence of chronic diseases, growing academic & government investments in genomics & proteomics research, rising demand for high-quality research tools for data reproducibility, and the increasing focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.

Key Market Players

The global microfluidics market is highly competitive, with a large number of global and local market players competing for higher market shares. Danaher Corporation (US), Thermo Fisher Scientific (US), PerkinElmer Inc. (US), Agilent Technologies (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), F. Hoffmann-La Roche (Switzerland), Illumina, Inc. (US), Fluidigm Microfluidics (US), Abbott Laboratories (US), and QIAGEN (Netherlands) are some of the prominent players in the microfluidic-based devices market.

The prominent players in the global microfluidic components market include Parker-Hannifin Corporation (US), Fluigent SA (France), Idex Corporation (US), Camozzi Automation Spa Societ� Unipersonale (Italy), Gems Sensors and Control (US), Aignep S.P.A. (Italy), SMC Corporation (Japan), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), Microfluidic ChipShop (Germany), Micronit Microtechnologies (Netherlands), and MicroLiquid (Spain).

Danaher Corporation (US) was the leading player in the microfluidics market. Danaher is a science and technology innovator, with a global family of more than 20 operating sub-companies. Of all the companies under Danaher Corporation, Cepheid (US), Beckman Coulter, Inc. (US), AB Sciex LLC (US), and Molecular Devices, LLC (US) are currently engaged in providing solutions for microfluidics. The company has strategically enhanced its presence in the global microfluidics market by pursuing several inorganic and organic growth strategies. The company has facilities in over 60 countries, which include 336 major manufacturing and distribution facilities; 160 of the total facilities are located in the US in over 25 states, and 176 are located outside the US in over 30 other countries (primarily in Europe and to a lesser extent in Asia and the rest of North America, South America, and Australia).

Thermo Fisher Scientific (US) is a global player in the microfluidics market, with broad geographic coverage. The company has maintained its leading position in the market through strong distribution networks across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In addition, it has five well-established brands, namely, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. The company emphasizes on developing and introducing new and improved products through continued R&D activities. The company focuses on strategic collaborations to come up with enhanced solutions and strengthen its product portfolio in the microfluidics market.

Scope of the Report:

Report Metric	Details
Market size available for years	2018�2025
Base year considered	2019
Forecast period	2020�2025
Forecast units	Value (USD)
Segments covered	Product, Application, End User, and Region
Geographies covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Companies covered	Danaher Corporation (US), Thermo Fisher Scientific (US), PerkinElmer Inc. (US), Agilent Technologies (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), F. Hoffmann-La Roche (Switzerland), Illumina, Inc. (US), Fluidigm Microfluidics (US), Abbott Laboratories (US), QIAGEN (Netherlands), Parker-Hannifin Corporation (US), Fluigent SA (France), Idex Corporation (US), Camozzi Automation Spa Societ� Unipersonale (Italy), Gems Sensors and Control (US), Aignep S.P.A. (Italy), SMC Corporation (Japan), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), Microfluidic ChipShop (Germany), Micronit Microtechnologies (Netherlands), and MicroLiquid (Spain).

The research report categorizes the market into the following segments and subsegments:

By Product

Microfluidic-based Devices
Microfluidic Components
- Microfluidic chips
- Flow and pressure sensors
- Flow and pressure controllers
- Micropumps
- Microfluidic valves
- Microneedles
- Other components

By Application

In Vitro Diagnostics
- PoC Testing
- Clinical Diagnostics
- Veterinary Diagnostics
Pharmaceutical, Life Science Research, and Manufacturing
- Lab Analytics
  - Proteomic Analysis
  - Genomic Analysis
  - Cell-based Assays
  - Capillary Electrophoresis
- Microdispensing
- Microreaction
Therapeutics
- Drug Delivery
- Wearable Devices

By End User

Hospitals & Diagnostic Centers
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies

By Region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLA)
Middle East & Africa

Recent Developments

In March 2020, Becton, Dickinson, and Company (US) received CE approval for the VIASURE SARS-CoV-2 Real-time PCR detection kit adapted for the BD MAX System for detection of COVID-19.
In March 2020, Thermo Fisher Scientific (US) received CE Mark approval for a diagnostic test to detect COVID-19. This test uses TaqPath Assay and real-time PCR technology. The company also received Emergency Use Authorization (EUA) from the US FDA.
In February 2020, Cepheid (US) collaborated with Sherlock Biosciences (US) to explore the development of new cutting-edge molecular diagnostic tests for COVID-19. They are combining Sherlock Biosciences' SHERLOCK, a CRISPR-based technology (that can identify virtually any genetic target) with Cepheid's GeneXpert Systems.
In August 2019, Agilent Technologies (US) acquired BioTek Instruments, Inc. (US) to expand its presence and expertise in cell analysis and strengthen its position in the large and growing immune-oncology and immunotherapy areas.

Critical questions the report answers:

Where will these developments take the industry in the mid-to-long term?
What are the recent trends in the microfluidics market?
What are the major market dynamics and their impact on overall market growth?
What is the global scenario of the microfluidics market?
What initiatives are players undertaking, especially in light of global events such as the COVID-19 pandemic?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION AND SCOPE
           1.2.1 MARKETS COVERED
           1.2.2 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 29)
    2.1 RESEARCH APPROACH
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
    2.2 MARKET SIZE ESTIMATION
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 43)

4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 GROWTH POTENTIAL OF THE MICROFLUIDICS MARKET
    4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER
    4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    4.4 MICROFLUIDICS MARKET, BY REGION
    4.5 MICROFLUIDICS MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW (Page No. - 52)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Rising demand for point-of-care testing
                    5.2.1.2 Technological advancements
                    5.2.1.3 Increasing focus on data precision and accuracy
                    5.2.1.4 Fast returns on investment
                    5.2.1.5 Faster testing and improved portability through microfluidic chip miniaturization
                    5.2.1.6 Entry of new players and launch of new and advanced products
           5.2.2 RESTRAINTS
                    5.2.2.1 Complex and time-consuming regulatory approval process
                    5.2.2.2 Incorporation of microfluidics into existing workflows
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emergence of microfluidic-based 3D cell culture systems, such as organ-on-a-chip
                    5.2.3.2 Asia�a key growth hotspot
                    5.2.3.3 Expanding applications of drug delivery technologies
                    5.2.3.4 Growing applications of microfluidics
           5.2.4 CHALLENGES
                    5.2.4.1 Standardization/commercialization of microfluidic devices

6 INDUSTRY INSIGHTS (Page No. - 61)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 SHIFTING TREND TOWARDS EHEALTH DIAGNOSTICS WITH THE INTEGRATION OF MICROFLUIDICS-BASED POC DEVICES, EPIDERMAL ELECTRONICS,AND IOT
           6.2.2 ADOPTION OF 3D PRINTING IN MICROFLUIDICS
           6.2.3 SHIFTING TREND TOWARDS THE ADOPTION OF POLYMERS
           6.2.4 UNIVERSITIES ACTIVELY INVESTING IN MICROFLUIDIC STARTUPS AND LARGE PLAYERS ACQUIRING SMALL PLAYERS
    6.3 ANALYSIS OF PARENT MARKETS
    6.4 EVOLUTION OF MICROFLUIDICS IN HEALTHCARE
    6.5 VALUE CHAIN ANALYSIS
           6.5.1 MICROFLUIDIC COMPONENTS PROCUREMENT MODEL OF MAJOR PLAYERS

7 MICROFLUIDICS MARKET, BY PRODUCT (Page No. - 74)
    7.1 INTRODUCTION
    7.2 MICROFLUIDIC-BASED DEVICES
           7.2.1 INCREASING ADOPTION OF MICROFLUIDIC DEVICES OWING TO THE VARIOUS ADVANTAGES OFFERED BY THEM TO DRIVE MARKET GROWTH
    7.3 MICROFLUIDIC COMPONENTS
           7.3.1 MICROFLUIDIC CHIPS
                    7.3.1.1 Microfluidic chips reduce the analysis time by increasing automation and consume low volumes of samples
           7.3.2 FLOW AND PRESSURE SENSORS
                    7.3.2.1 These devices offer a range of advantages, due to which they are increasingly used in laboratories and research institutes
           7.3.3 FLOW AND PRESSURE CONTROLLERS
                    7.3.3.1 Due to high accuracy and control stability, pressure controllers are suitable as references for laboratories
           7.3.4 MICROPUMPS
                    7.3.4.1 Need for precision in fluid control and device miniaturization has favored the growth of the micropumps market
           7.3.5 MICROFLUIDIC VALVES
                    7.3.5.1 Valves are a vital component in microfluidic devices�a key factor driving market growth
           7.3.6 MICRONEEDLES
                    7.3.6.1 Small size of microneedles leaves dermal nerves and blood vessels unaffected, ensuring a painless procedure
           7.3.7 OTHER COMPONENTS

8 MICROFLUIDICS MARKET, BY APPLICATION (Page No. - 96)
    8.1 INTRODUCTION
    8.2 IN VITRO DIAGNOSTICS
           8.2.1 POINT-OF-CARE TESTING
                    8.2.1.1 Point-of-care testing is the largest application segment in the microfluidics market for in vitro diagnostics
           8.2.2 CLINICAL DIAGNOSTICS
                    8.2.2.1 Increase in viral outbreaks to drive growth in the clinical diagnostics segment
           8.2.3 VETERINARY DIAGNOSTICS
                    8.2.3.1 Growing need for low-cost, rapid, and reliable diagnostic results in veterinary medicine to drive market growth
    8.3 PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING
           8.3.1 LAB ANALYTICS
                    8.3.1.1 Proteomic analysis
                               8.3.1.1.1 Increasing demand for rapid proteomic analysis for drug development is boosting the adoption of lab-on-a-chip devices
                    8.3.1.2 Genomic analysis
                               8.3.1.2.1 Increasing focus on the decoding of genomes to boost the adoption of microfluidics in genomics
                    8.3.1.3 Cell-based assays
                               8.3.1.3.1 Increasing focus on microfluidic cell-based assays for rapid drug development aids market growth
                    8.3.1.4 Capillary electrophoresis
                               8.3.1.4.1 Combination of microfluidic capillary electrophoresis with other technologies to drive overall market growth
           8.3.2 MICRODISPENSING
                    8.3.2.1 Advantages such as less sample and reagent consumption and ease of operation drive the adoption of microdispensing systems
           8.3.3 MICROREACTION
                    8.3.3.1 Increasing need for optimization in the research and production process using microfluidic techniques drives the market growth
    8.4 THERAPEUTICS
           8.4.1 DRUG DELIVERY
                    8.4.1.1 Expanding applications of microfluidic in development of drug delivery platform are a key driver for market growth
           8.4.2 WEARABLE DEVICS
                    8.4.2.1 Increasing demand for microfluidics-integrated wearable devices for patient vital sign monitoring drives overall growth

9 MICROFLUIDICS MARKET, BY END USER (Page No. - 118)
    9.1 INTRODUCTION
    9.2 HOSPITALS AND DIAGNOSTIC CENTERS
           9.2.1 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE LARGEST END USERS OF MICROFLUIDICS
    9.3 ACADEMIC AND RESEARCH INSTITUTES
           9.3.1 USE OF MICROFLUIDICS IN RESEARCH IS EXPECTED TO INCREASE WITH GROWING FUNDING IN THE FIELD
    9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
           9.4.1 INCREASING FOCUS ON LAUNCHING QUALITY DRUGS TO SUPPORT MARKET GROWTH

10 MICROFLUIDICS MARKET, BY REGION (Page No. - 126)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
             10.2.1 US
                        10.2.1.1 The US dominates the North American microfluidics market
             10.2.2 CANADA
                        10.2.2.1 Strong infrastructure and availability of funding for biomedical research will support market growth
     10.3 EUROPE
             10.3.1 GERMANY
                        10.3.1.1 Germany holds the largest share in the European market
             10.3.2 FRANCE
                        10.3.2.1 Genomics and proteomics research is strongly supported by the government of France
             10.3.3 UK
                        10.3.3.1 Increasing incidence of infectious diseases such as COVID-19 drives the growth of PoC testing and microfluidics
             10.3.4 ITALY
                        10.3.4.1 Increasing demand for PoC testing aids market growth
             10.3.5 SPAIN
                        10.3.5.1 Increasing incidence of infectious and chronic diseases drives the growth of the market
             10.3.6 REST OF EUROPE
     10.4 ASIA PACIFIC
             10.4.1 CHINA
                        10.4.1.1 China holds a major share in the Asia Pacific microfluidics market
             10.4.2 JAPAN
                        10.4.2.1 Adoption of technologically advanced laboratory analytical instruments in research to drive market growth in Japan
             10.4.3 INDIA
                        10.4.3.1 Increasing pharma R&D and government funding in the biotechnology sector is a major source of market growth
             10.4.4 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA
             10.5.1 BRAZIL
                        10.5.1.1 Pharmaceutical & biologics QC to drive market growth in Brazil
             10.5.2 MEXICO
                        10.5.2.1 Rising prevalence of chronic diseases drives the growth of the microfluidics market in Mexico
             10.5.3 REST OF LATIN AMERICA
     10.6 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE (Page No. - 203)
     11.1 OVERVIEW
     11.2 PRODUCT PORTFOLIO MATRIX
     11.3 COMPETITIVE SITUATION AND TRENDS
             11.3.1 PRODUCT LAUNCHES
             11.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
             11.3.3 ACQUISITIONS
             11.3.4 EXPANSIONS
     11.4 COMPETITIVE LEADERSHIP MAPPING
             11.4.1 VISIONARY LEADERS
             11.4.2 INNOVATORS
             11.4.3 DYNAMIC DIFFERENTIATORS
             11.4.4 EMERGING COMPANIES

12 COMPANY PROFILES (Page No. - 214)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, Strategic Overview, Competitive Analysis)*
     12.1 PARKER-HANNIFIN CORPORATION
     12.2 SMC CORPORATION
     12.3 IDEX CORPORATION
     12.4 FLUIGENT SA
     12.5 DOLOMITE MICROFLUIDICS
     12.6 AIGNEP S.P.A.
     12.7 CAMOZZI AUTOMATION SPA SOCIET� UNIPERSONALE
     12.8 ELVEFLOW
     12.9 CELLIX LTD.
     12.10 FORTIVE CORPORATION
     12.11 DANAHER CORPORATION
     12.12 THERMO FISHER SCIENTIFIC INC.
     12.13 PERKINELMER, INC.
     12.14 AGILENT TECHNOLOGIES, INC.
     12.15 BIO-RAD LABORATORIES, INC.
     12.16 BECTON, DICKINSON AND COMPANY
     12.17 ILLUMINA, INC.
     12.18 F. HOFFMANN-LA ROCHE LTD.
     12.19 FLUIDIGM CORPORATION
     12.20 ABBOTT LABORATORIES
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Strategic Overview, Competitive Analysis might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 277)
     13.1 INSIGHTS FROM INDUSTRY EXPERTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS� SUBSCRIPTION PORTAL
     13.4 AVAILABLE CUSTOMIZATIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS

LIST OF TABLES (218 Tables)

TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
TABLE 2 SOME OF THE NEW PRODUCTS LAUNCHED BY MAJOR PLAYERS IN THE LAST THREE YEARS HAVE BEEN MENTIONED BELOW:
TABLE 3 IMPACT ANALYSIS: MARKET DRIVERS
TABLE 4 IMPACT ANALYSIS: MARKET RESTRAINTS
TABLE 5 IMPACT ANALYSIS: MARKET OPPORTUNITIES
TABLE 6 IMPACT ANALYSIS: MARKET CHALLENGES
TABLE 7 LIST OF UNIVERSITY STARTUPS IN THE MICROFLUIDICS MARKET
TABLE 8 MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 9 MICROFLUIDIC-BASED DEVICES MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 10 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 11 MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 12 MICROFLUIDIC CHIPS AVAILABLE IN THE MARKET
TABLE 13 MICROFLUIDIC CHIPS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 14 FLOW AND PRESSURE SENSORS AVAILABLE IN THE MARKET
TABLE 15 FLOW AND PRESSURE SENSORS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 16 FLOW AND PRESSURE CONTROLLERS AVAILABLE IN THE MARKET
TABLE 17 FLOW AND PRESSURE CONTROLLERS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 18 MICROPUMPS AVAILABLE IN THE MARKET
TABLE 19 MICROPUMPS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 20 MICROFLUIDIC VALVES AVAILABLE IN THE MARKET
TABLE 21 MICROFLUIDIC VALVES MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 22 MICRONEEDLES AVAILABLE IN THE MARKET
TABLE 23 MICRONEEDLES MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 24 OTHER MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 25 MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 26 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 27 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 28 MICROFLUIDICS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY,2018�2025 (USD MILLION)
TABLE 29 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 30 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 31 MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 32 MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 33 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 34 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 35 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 36 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 37 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 38 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 39 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 40 MICROFLUIDICS MARKET FOR MICROREACTION, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 41 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 42 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 43 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 44 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 45 MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 46 MICROFLUIDICS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 47 MICROFLUIDICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 48 MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 49 MICROFLUIDICS MARKET, BY REGION, 2018�2025 (USD MILLION)
TABLE 50 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 51 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 52 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 53 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 54 NORTH AMERICA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 55 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 56 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 57 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 58 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 59 US: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 60 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 61 US: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 62 US: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 63 US: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 64 US: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 65 US: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 66 US: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 67 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 68 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 69 CANADA: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 70 CANADA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 71 CANADA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 72 CANADA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 73 CANADA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 74 CANADA: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 75 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 76 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 77 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 78 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 79 EUROPE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 80 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 81 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 82 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 83 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 84 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 85 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 86 GERMANY: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 87 GERMANY: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 88 GERMANY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 89 GERMANY: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 90 GERMANY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 91 GERMANY: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 92 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 93 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 94 FRANCE: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 95 FRANCE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 96 FRANCE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 97 FRANCE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 98 FRANCE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 99 FRANCE: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 100 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 101 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 102 UK: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 103 UK: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 104 UK: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 105 UK: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 106 UK: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 107 UK: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 108 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 109 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 110 ITALY: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 111 ITALY: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 112 ITALY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 113 ITALY: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 114 ITALY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 115 ITALY: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 116 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 117 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 118 SPAIN: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 119 SPAIN: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 120 SPAIN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 121 SPAIN: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 122 SPAIN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 123 SPAIN: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 124 ROE: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 125 ROE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 126 ROE: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 127 ROE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 128 ROE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 129 ROE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 130 ROE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 131 ROE: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 132 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 133 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 134 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 135 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 136 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 137 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 138 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 139 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 140 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 141 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 142 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 143 CHINA: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 144 CHINA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 145 CHINA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 146 CHINA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 147 CHINA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 148 CHINA: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 149 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 150 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 151 JAPAN: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 152 JAPAN: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 153 JAPAN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 154 JAPAN: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 155 JAPAN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 156 JAPAN: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 157 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 158 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 159 INDIA: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 160 INDIA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 161 INDIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 162 INDIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 163 INDIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 164 INDIA: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 165 ROAPAC: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 166 ROAPAC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 167 ROAPAC: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 168 ROAPAC: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 169 ROAPAC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 170 ROAPAC: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 171 ROAPAC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 172 ROAPAC: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 173 LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)
TABLE 174 LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 175 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 176 LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 177 LATIN AMERICA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 178 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 179 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 180 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 181 LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 182 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 183 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 184 BRAZIL: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 185 BRAZIL: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 186 BRAZIL: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 187 BRAZIL: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 188 BRAZIL: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 189 BRAZIL: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 190 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 191 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 192 MEXICO: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 193 MEXICO: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 194 MEXICO: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 195 MEXICO: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 196 MEXICO: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 197 MEXICO: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 198 ROLA: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 199 ROLA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 200 ROLA: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 201 ROLA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 202 ROLA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 203 ROLA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 204 ROLA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 205 ROLA: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 206 MEA: MICROFLUIDICS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)
TABLE 207 MEA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2018�2025 (USD MILLION)
TABLE 208 MEA: MICROFLUIDICS MARKET, BY APPLICATION, 2018�2025 (USD MILLION)
TABLE 209 MEA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 210 MEA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2018�2025 (USD MILLION)
TABLE 211 MEA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 212 MEA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2018�2025 (USD MILLION)
TABLE 213 MEA: MICROFLUIDICS MARKET, BY END USER, 2018�2025 (USD MILLION)
TABLE 214 PRODUCT PORTFOLIO ANALYSIS OF MAJOR PLAYERS IN THE MARKET
TABLE 215 PRODUCT LAUNCHES & APPROVALS
TABLE 216 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 217 ACQUISITIONS
TABLE 218 EXPANSIONS

LIST OF FIGURES (57 Figures)

FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE)
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE)
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 REVENUE SHARE ANALYSIS
FIGURE 7 SUPPLY-SIDE ANALYSIS OF THE MICROFLUIDICS MARKET
FIGURE 8 MICROFLUIDICS MARKET: CAGR PROJECTIONS FROM THE SUPPLY SIDE
FIGURE 9 TOP-DOWN APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
FIGURE 11 MICROFLUIDICS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 12 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 13 MICROFLUIDICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 14 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 15 MICROFLUIDICS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 16 GEOGRAPHIC ANALYSIS: GLOBAL MICROFLUIDICS MARKET
FIGURE 17 RISING DEMAND FOR POINT-OF-CARE TESTING IS DRIVING THE GROWTH OF THE GLOBAL MICROFLUIDICS MARKET
FIGURE 18 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MICROFLUIDICS MARKET IN 2019
FIGURE 19 US ACCOUNTED FOR THE LARGEST SHARE OF THE MICROFLUIDICS MARKET IN 2019
FIGURE 20 NORTH AMERICA TO DOMINATE THE GLOBAL MICROFLUIDICS MARKET DURING THE FORECAST PERIOD
FIGURE 21 HIGH GROWTH OPPORTUNITIES IN BOTH DEVELOPING AND DEVELOPED MARKETS DURING THE FORECAST PERIOD
FIGURE 22 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 23 GLOBAL CANCER INCIDENCE, 2015�2040
FIGURE 24 SHIFT TOWARDS EHEALTH DIAGNOSTICS WITH THE INTEGRATION OF MICROFLUIDIC-BASED POC DEVICES, EPIDERMAL ELECTRONICS, AND IOT
FIGURE 25 PROTEOMICS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 26 IN VITRO DIAGNOSTICS MARKET SNAPSHOT
FIGURE 27 POINT-OF-CARE DIAGNOSTICS MARKET SNAPSHOT
FIGURE 28 PROTEOMICS MARKET SNAPSHOT
FIGURE 29 GENOMICS MARKET SNAPSHOT
FIGURE 30 CAPILLARY ELECTROPHORESIS SYSTEMS MARKET SNAPSHOT
FIGURE 31 VALUE CHAIN ANALYSIS
FIGURE 32 LAB ANALYTICS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET FOR PHARMACEUTICAL AND LIFE SCIENCE RESEARCH AND MANUFACTURING IN 2019
FIGURE 33 PROTEOMIC ANALYSIS TO DOMINATE THE LAB ANALYTICS MARKET DURING THE FORECAST PERIOD
FIGURE 34 DRUG DELIVERY APPLICATIONS TO DOMINATE THE THERAPEUTICS MARKET DURING THE FORECAST PERIOD
FIGURE 35 LIFE SCIENCES R&D SPENDING, 2017�2019
FIGURE 36 FDA APPROVALS FOR PERSONALIZED MEDICINES (2014�2018)
FIGURE 37 MICROFLUIDICS MARKET: GEOGRAPHIC SNAPSHOT (2019)
FIGURE 38 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT
FIGURE 39 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT
FIGURE 40 KEY DEVELOPMENTS IN THE MICROFLUIDICS MARKET (2018�2020)
FIGURE 41 COMPARATIVE ASSESSMENT OF KEY PLAYERS FOR R&D EXPENDITURE (2017 VS. 2019)
FIGURE 42 COMPETITIVE ASSESSMENT OF KEY PLAYERS IN THE MICROFLUIDICS MARKET, BY REGION (2019)
FIGURE 43 MICROFLUIDICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
FIGURE 44 PARKER-HANNIFIN CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 45 SMC CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 46 IDEX CORPORATION :COMPANY SNAPSHOT (2019)
FIGURE 47 FORTIVE CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
FIGURE 50 PERKINELMER, INC.: COMPANY SNAPSHOT (2019)
FIGURE 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
FIGURE 52 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
FIGURE 53 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
FIGURE 54 ILLUMINA, INC.: COMPANY SNAPSHOT (2019)
FIGURE 55 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
FIGURE 56 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 57 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)

The global microfluidics market study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the microfluidics market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, product managers, business development managers, technology and innovation directors of companies providing microfluidics, key opinion leaders, and suppliers and distributors. The industry experts from the demand side include hospitals, diagnostic centers, academic institutes, and research centers, as well as pharmaceutical and biotechnology companies.

Following the breakdown of primary respondents-

Microfluidics Market, by Region, 2023 (USD Billion)

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product, application, end user, and region).

Data Triangulation

After arriving at the market size, the total microfluidics market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

To define, describe, and forecast the global microfluidics market by product, application, end user, and region
To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges)
To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the microfluidics market in five regions (along with major countries)�North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
To profile key players in the microfluidics market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments such as acquisitions; new product launches; product approvals, and collaborations, partnerships, and agreements; of the leading players in the global microfluidics market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakdown of the Rest of Asia Pacific microfluidics market into Australia, New Zealand, South Korea, Malaysia, and other countries
Further breakdown of the Rest of Europe microfluidics market into Belgium, Russia, the Netherlands, Switzerland, and other countries
Further breakdown of the Rest of Latin America microfluidics market into Argentina, Colombia, Chile, Ecuador, and others